Humana Inc. (NYSE:HUM) Shares Sold by Johnson Financial Group Inc.

by · The Cerbat Gem

Johnson Financial Group Inc. lowered its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 71.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 488 shares of the insurance provider’s stock after selling 1,239 shares during the quarter. Johnson Financial Group Inc.’s holdings in Humana were worth $124,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider’s stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Dodge & Cox grew its position in Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider’s stock worth $2,587,345,000 after buying an additional 5,264,045 shares during the last quarter. Pzena Investment Management LLC increased its holdings in shares of Humana by 44.0% in the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider’s stock valued at $915,736,000 after buying an additional 1,103,132 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider’s stock valued at $729,658,000 after acquiring an additional 63,562 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Humana by 29.8% during the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider’s stock worth $608,348,000 after acquiring an additional 550,692 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Robert W. Baird boosted their price target on shares of Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, April 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Monday, April 7th. Finally, Guggenheim assumed coverage on Humana in a report on Wednesday, April 9th. They issued a “buy” rating and a $326.00 target price for the company. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $284.90.

View Our Latest Report on HUM

Humana Trading Down 1.5 %

Shares of NYSE:HUM opened at $263.92 on Monday. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The firm has a fifty day moving average price of $266.35 and a 200 day moving average price of $270.81. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $31.85 billion, a PE ratio of 26.52, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Friday, June 27th. Humana’s dividend payout ratio is 35.58%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles